Geode Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $7.89M | Buy |
|
|||||
|
2022
Q3 | $11.2M | Buy |
|
|||||
|
2022
Q2 | $13.9M | Buy |
|
|||||
|
2022
Q1 | $11.6M | Sell |
|
|||||
|
2021
Q4 | $24.6M | Buy |
|
|||||
|
2021
Q3 | $38.6M | Buy |
|
|||||
|
2021
Q2 | $42.7M | Buy |
|
|||||
|
2021
Q1 | $33.5M | Buy |
|
|||||
|
2020
Q4 | $24.8M | Buy |
|
|||||
|
2020
Q3 | $34.9M | Buy |
|
|||||
|
2020
Q2 | $15.3M | Buy |
|
|||||
|
2020
Q1 | $3.37M | Buy |
|
|||||
|
2019
Q4 | $5.78M | Buy |
|
|||||
|
2019
Q3 | $3.34M | Buy |
|
|||||
|
2019
Q2 | $3.89M | Buy |
|
|||||
|
2019
Q1 | $6.32M | Buy |
|
|||||
|
2018
Q4 | $2.52M | Buy |
|
|||||
|
2018
Q3 | $4.36M | Buy |
|
|||||
|
2018
Q2 | $5.56M | Buy |
|
|||||
|
2018
Q1 | $2.53M | Buy |
|
|||||
|
2017
Q4 | $1.75M | Hold |
|
|||||
|
2017
Q3 | $783K | Buy |
|
|||||
|
2017
Q2 | $805K | Buy |
|
|||||
|
2017
Q1 | $1.45M | Buy |
|
|||||
|
2016
Q4 | $1.73M | Buy |
|
|||||
|
2016
Q3 | $2.73M | Buy |
|
|||||
|
2016
Q2 | $1.08M | Buy |
|
|||||
|
2016
Q1 | $986 | Buy |
|
|||||
|
2015
Q4 | $1.55M | Sell |
|
|||||
|
2015
Q3 | $1.63M | Sell |
|
|||||
|
2015
Q2 | $3.6M | Buy |
|
|||||
|
2015
Q1 | $1.27M | Buy |
|
|||||
|
2014
Q4 | $1.09M | Buy |
|
|||||
|
2014
Q3 | $387K | Buy |
|
|||||
|
2014
Q2 | $565K | Buy |
|
|||||
|
2014
Q1 | $654K | Buy |
|